Advertisement

Intensive Care Medicine

, Volume 34, Issue 3, pp 538–542 | Cite as

International critical care hospital pharmacist activities

  • Jaclyn M. LeBlancEmail author
  • Enrique C. Seoane-Vazquez
  • Trudy C. Arbo
  • Joseph F. Dasta
Brief Report

Abstract

Objective

The role of critical care pharmacists in the United States has recently been documented; however, little information exists about the role of international critical care pharmacists. The objective of this study was to describe the duties and activities of international pharmacists who practice in critical care.

Design

Web-based survey.

Setting

Hospitals outside of the United States.

Participants

International pharmacists with > 50% of their time dedicated to critical care.

Interventions

An invitation to answer the survey was sent to pharmacists via mail, e-mail or newsletter. Pharmacists were requested to answer based on their current practice. The survey was open from November 2004 to November 2005.

Measurements and results

Data were collected on demographics and clinical and non-clinical activities. The final analysis included 168 pharmacists with dedicated critical care responsibilities. Respondents indicated 74.4% attended medical rounds and 54.8% were involved in research. Therapeutic drug monitoring was completed by 72.6% of pharmacists, with the most commonly monitored medications being aminoglycosides and vancomycin. While 41.7% of pharmacists personally dispensed medications, 13% and 8.4% were involved in directly preparing intravenous medications or total parenteral nutrition, respectively.

Conclusions

International critical care pharmacists participate in a wide range of activities from attending ward rounds to dispensing of medications. We hope the broad range of pharmacist activities described herein will increase the involvement of the pharmacist in the critical care team worldwide.

Keywords

Pharmacy service, hospital Internationality Pharmacists Critical care 

Supplementary material

134_2007_918_MOESM1_ESM.doc (22 kb)
Electronic Supplementary Material (DOC 22K)

References

  1. 1.
    Dasta J (1982) Critical care therapeutics: a frontier for clinical pharmacy. Drug Int Clin Pharm 16:398–399Google Scholar
  2. 2.
    Dasta J (1996) Evolving role of the pharmacist in the critical care environment. J Clin Anesth 8:99S–102SPubMedCrossRefGoogle Scholar
  3. 3.
    Dasta J (2006) Critical care. Ann Pharmacother 40:736–737PubMedCrossRefGoogle Scholar
  4. 4.
    Montazeri M, Cook D (1994) Impact of a clinical pharmacist in a multidisciplinary intensive care unit. Crit Care Med 22:1044–1048PubMedCrossRefGoogle Scholar
  5. 5.
    Smythe M, Shah P, Spiteri T, Lucarotti R, Begle R (1998) Pharmaceutical care in medical progressive care patients. Ann Pharmacother 32:294–299PubMedCrossRefGoogle Scholar
  6. 6.
    Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, Bates DW (1999) Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 282:267–270PubMedCrossRefGoogle Scholar
  7. 7.
    Dooley M, Allen K, Doecke C, Galbraith K, Taylor G, Bright J, Carey D (2004) A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Brit J Clin Pharmacol 57:513–521CrossRefGoogle Scholar
  8. 8.
    Kane S, Weber R, Dasta J (2003) The impact of critical care pharmacists on enhancing patient outcomes. Int Care Med 29:691–698Google Scholar
  9. 9.
    Razi Z, Latif S, Shamim R (2002) Establishing clinical pharmacy services in a Pakistani intensive care unit. Am J Health Syst Pharm 59:1888–1889PubMedGoogle Scholar
  10. 10.
    Zaidi S, Hassan Y, Postma M, Ng S (2003) Impact of pharmacist recommendations on the cost of drug therapy in ICU patients at a Malaysian hospital. Pharm World Sci 25:299–302PubMedCrossRefGoogle Scholar
  11. 11.
    Rudis M, Brandl K (2000) Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy Task Force on Critical Care Pharmacy Services. Crit Care Med 28:3746–3750PubMedCrossRefGoogle Scholar
  12. 12.
    Timmins A (2000) The contribution of the intensive care pharmacist in the United Kingdom. Pharm J 265:341–344Google Scholar
  13. 13.
    MacLaren R, Devlin J, Martin S, Dasta J, Rudis M, Bond C (2006) Critical care pharmacy services in United States hospitals. Ann Pharmacother 40:612–618PubMedCrossRefGoogle Scholar
  14. 14.
    Dasta J, Segal R, Cunningham A (1989) National survey of critical-care pharmaceutical services. Am J Hosp Pharm 46:2308–2312PubMedGoogle Scholar
  15. 15.
    LeBlanc J, Seoane-Vazquez E, Dasta J (2007) Global report of hospital pharmacist activities. Am J Health Syst Pharm 64:1748–1755PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Jaclyn M. LeBlanc
    • 1
    • 4
    Email author
  • Enrique C. Seoane-Vazquez
    • 1
    • 2
  • Trudy C. Arbo
    • 3
  • Joseph F. Dasta
    • 1
  1. 1.College of PharmacyThe Ohio State UniversityColumbusUSA
  2. 2.School of Public HealthThe Ohio State UniversityColumbusUSA
  3. 3.Clinical Pharmacy Practice Leader in Cardiology, Box 2100, c/o Department of PharmacyAtlantic Health Sciences CorporationSaint JohnCanada
  4. 4.Clinical Pharmacy Practice Leader in Research and Education, Box 2100, c/o Department of PharmacyAtlantic Health Sciences CorporationSaint JohnCanada

Personalised recommendations